Mark Altmeyer: Founder and CEO of Arvelle Therapeutics

Portrait of Mark Altmeyer

Mark Altmeyer, founder and CEO of Arvelle Therapeutics, speaks with BioBoss host John Simboli. Hear Mark’s thoughts about leadership and how Arvelle is working to bring new solutions to people living with epilepsy and CNS disorders.

Computer chip/molecular design concept animation.
TandemAI

Discovery as a Service

Steinway Annual Report cover detail
Steinway Musical Instruments

Extending Our Reach

Psivant Employees in front of monitor with molecular model.
Psivant Therapeutics

Designing Better Therapeutics, Atom by Atom